A clinical study of Budesonide delayed release made by 3D printing using Melt Extrusion Deposition for the treatment of IgAN
Latest Information Update: 06 Mar 2025
At a glance
- Drugs Budesonide (Primary)
- Indications IgA nephropathy
- Focus Adverse reactions
Most Recent Events
- 06 Mar 2025 New trial record
- 20 Feb 2025 Results presented Triastekin the Media Release.